• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

整合素α5β1在尿激酶(uPA)/尿激酶受体(uPAR,CD87)信号传导中的关键作用。

Critical role of integrin alpha 5 beta 1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling.

作者信息

Tarui Takehiko, Andronicos Nicholas, Czekay Ralf-Peter, Mazar Andrew P, Bdeir Khalil, Parry Graham C, Kuo Alice, Loskutoff David J, Cines Douglas B, Takada Yoshikazu

机构信息

Department of Cell Biology, The Scripps Research Institute, La Jolla, California 92037, USA.

出版信息

J Biol Chem. 2003 Aug 8;278(32):29863-72. doi: 10.1074/jbc.M304694200. Epub 2003 May 15.

DOI:10.1074/jbc.M304694200
PMID:12754207
Abstract

Urokinase-type plasminogen activator (uPA) induces cell adhesion and chemotactic movement. uPA signaling requires its binding to uPA receptor (uPAR/CD87), but how glycosylphosphatidylinositol-anchored uPAR mediates signaling is unclear. uPAR is a ligand for several integrins (e.g. alpha 5 beta 1) and supports cell-cell interaction by binding to integrins on apposing cells (in trans). We studied whether binding of uPAR to alpha 5 beta 1 in cis is involved in adhesion and migration of Chinese hamster ovary cells in response to immobilized uPA. This process was temperature-sensitive and required mitogen-activated protein kinase activation. Anti-uPAR antibody or depletion of uPAR blocked, whereas overexpression of uPAR enhanced, cell adhesion to uPA. Adhesion to uPA was also blocked by deletion of the growth factor domain (GFD) of uPA and by anti-GFD antibody, whereas neither the isolated uPA kringle nor serine protease domain supported adhesion directly. Interestingly, anti-alpha 5 antibody, RGD peptide, and function-blocking mutations in alpha 5 beta 1 blocked adhesion to uPA. uPA-induced cell migration also required GFD, uPAR, and alpha 5 beta 1, but alpha 5 beta 1 alone did not support uPA-induced adhesion and migration. Thus, binding of uPA causes uPAR to act as a ligand for alpha 5 beta 1 to induce cell adhesion, intracellular signaling, and cell migration. We demonstrated that uPA induced RGD-dependent binding of uPAR to alpha 5 beta 1 in solution. These results suggest that uPA-induced adhesion and migration of Chinese hamster ovary cells occurs as a consequence of (a) uPA binding to uPAR through GFD, (b) the subsequent binding of a uPA.uPAR complex to alpha 5 beta 1 via uPAR, and (c) signal transduction through alpha 5 beta 1.

摘要

尿激酶型纤溶酶原激活剂(uPA)可诱导细胞黏附和趋化运动。uPA信号传导需要其与uPA受体(uPAR/CD87)结合,但糖基磷脂酰肌醇锚定的uPAR如何介导信号传导尚不清楚。uPAR是几种整合素(如α5β1)的配体,并通过与相邻细胞上的整合素(反式)结合来支持细胞间相互作用。我们研究了uPAR与α5β1顺式结合是否参与中国仓鼠卵巢细胞对固定化uPA的黏附和迁移。这个过程对温度敏感,并且需要丝裂原活化蛋白激酶激活。抗uPAR抗体或uPAR的缺失会阻断细胞对uPA的黏附,而uPAR的过表达则会增强这种黏附。uPA生长因子结构域(GFD)的缺失和抗GFD抗体也会阻断对uPA的黏附,而单独的uPA kringle或丝氨酸蛋白酶结构域都不能直接支持黏附。有趣地是,可以阻断对uPA的黏附。uPA诱导的细胞迁移也需要GFD、uPAR和α5β1,但单独的α5β1并不支持uPA诱导的黏附和迁移。因此,uPA的结合导致uPAR作为α5β1的配体,从而诱导细胞黏附、细胞内信号传导和细胞迁移。我们证明,uPA在溶液中诱导uPAR与α5β1的RGD依赖性结合。这些结果表明,uPA诱导中国仓鼠卵巢细胞的黏附和迁移是以下结果:(a)uPA通过GFD与uPAR结合;(b)随后uPA.uPAR复合物通过uPAR与α5β1结合;(c)通过α5β1进行信号转导。

相似文献

1
Critical role of integrin alpha 5 beta 1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling.整合素α5β1在尿激酶(uPA)/尿激酶受体(uPAR,CD87)信号传导中的关键作用。
J Biol Chem. 2003 Aug 8;278(32):29863-72. doi: 10.1074/jbc.M304694200. Epub 2003 May 15.
2
Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.尿激酶型纤溶酶原激活剂(uPA)kringle结构域与整合素αvβ3的直接相互作用可诱导信号转导并增强纤溶酶原激活。
Thromb Haemost. 2006 Mar;95(3):524-34. doi: 10.1160/TH05-06-0457.
3
Urokinase-type plasminogen activator receptor (CD87) is a ligand for integrins and mediates cell-cell interaction.尿激酶型纤溶酶原激活物受体(CD87)是整合素的配体,介导细胞间相互作用。
J Biol Chem. 2001 Feb 9;276(6):3983-90. doi: 10.1074/jbc.M008220200. Epub 2000 Oct 26.
4
Convergence of the adhesive and fibrinolytic systems: recognition of urokinase by integrin alpha Mbeta 2 as well as by the urokinase receptor regulates cell adhesion and migration.黏附系统与纤维蛋白溶解系统的汇聚:整合素αMβ2以及尿激酶受体对尿激酶的识别可调节细胞黏附和迁移。
Blood. 2003 Feb 15;101(4):1582-90. doi: 10.1182/blood-2002-06-1842. Epub 2002 Sep 26.
5
Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1.尿激酶受体通过与整合素α3β1相互作用促进β1整合素功能。
Mol Biol Cell. 2001 Oct;12(10):2975-86. doi: 10.1091/mbc.12.10.2975.
6
Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and alpha v beta 5 integrin.通过尿激酶连接肽区域与αvβ5整合素之间的新型相互作用激活尿激酶受体。
J Cell Sci. 2006 Aug 15;119(Pt 16):3424-34. doi: 10.1242/jcs.03067. Epub 2006 Aug 1.
7
Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling.尿激酶受体下调诱导人癌肿瘤休眠涉及整合素和丝裂原活化蛋白激酶信号传导。
J Cell Biol. 1999 Oct 4;147(1):89-104. doi: 10.1083/jcb.147.1.89.
8
Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.尿激酶型纤溶酶原激活剂与其受体结合,通过增强整合素介导的信号转导来刺激肿瘤细胞迁移。
Exp Cell Res. 1999 Jul 10;250(1):231-40. doi: 10.1006/excr.1999.4510.
9
Plasminogen activator inhibitors regulate cell adhesion through a uPAR-dependent mechanism.纤溶酶原激活物抑制剂通过一种依赖尿激酶型纤溶酶原激活物受体(uPAR)的机制调节细胞黏附。
J Cell Physiol. 2009 Sep;220(3):655-63. doi: 10.1002/jcp.21806.
10
An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration.一种不可切割的尿激酶型纤溶酶原激活物受体(uPAR)突变体可用于剖析uPA依赖性细胞迁移中的信号通路。
Mol Biol Cell. 2006 Jan;17(1):367-78. doi: 10.1091/mbc.e05-07-0635. Epub 2005 Nov 2.

引用本文的文献

1
Targeting integrin α5β1 in urological tumors: opportunities and challenges.靶向整合素α5β1在泌尿系统肿瘤中的应用:机遇与挑战
Front Oncol. 2023 Jul 6;13:1165073. doi: 10.3389/fonc.2023.1165073. eCollection 2023.
2
Self-anti-angiogenesis nanoparticles enhance anti-metastatic-tumor efficacy of chemotherapeutics.自抗血管生成纳米颗粒增强化疗药物的抗转移肿瘤疗效。
Bioact Mater. 2021 Nov 2;13:179-190. doi: 10.1016/j.bioactmat.2021.10.037. eCollection 2022 Jul.
3
Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer.
癌症中针对尿激酶及其受体的治疗策略
Cancers (Basel). 2022 Jan 19;14(3):498. doi: 10.3390/cancers14030498.
4
Expression and Pathogenic Analysis of Integrin Family Genes in Systemic Sclerosis.整合素家族基因在系统性硬化症中的表达及致病性分析
Front Med (Lausanne). 2021 Jul 20;8:674523. doi: 10.3389/fmed.2021.674523. eCollection 2021.
5
The Roles of Integrin α5β1 in Human Cancer.整合素α5β1在人类癌症中的作用。
Onco Targets Ther. 2020 Dec 31;13:13329-13344. doi: 10.2147/OTT.S273803. eCollection 2020.
6
Enhancement of Cutaneous Wound Healing by Dsg2 Augmentation of uPAR Secretion.通过 Dsg2 增强 uPAR 分泌增强皮肤伤口愈合。
J Invest Dermatol. 2018 Nov;138(11):2470-2479. doi: 10.1016/j.jid.2018.04.024. Epub 2018 May 9.
7
Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma.霍奇金淋巴瘤患者尿激酶型纤溶酶原激活物受体、可溶性尿激酶型纤溶酶原激活物受体及β1整合素的评估
Adv Biomed Res. 2017 Aug 28;6:108. doi: 10.4103/2277-9175.213668. eCollection 2017.
8
Vitronectin in the ascites of human ovarian carcinoma acts as a potent chemoattractant for ovarian carcinoma: Implication for metastasis by cancer stem cells.人卵巢癌腹水中的玻连蛋白可作为卵巢癌的强效趋化因子:对癌症干细胞转移的影响。
J Cancer Stem Cell Res. 2016;4. doi: 10.14343/JCSCR.2016.4e1005. Epub 2016 Nov 30.
9
A new class of orthosteric uPAR·uPA small-molecule antagonists are allosteric inhibitors of the uPAR·vitronectin interaction.一类新型的正向变构uPAR·uPA小分子拮抗剂是uPAR·玻连蛋白相互作用的别构抑制剂。
ACS Chem Biol. 2015 Jun 19;10(6):1521-34. doi: 10.1021/cb500832q. Epub 2015 Mar 31.
10
Soluble urokinase-type plasminogen activator receptor levels in patients with schizophrenia.精神分裂症患者可溶性尿激酶型纤溶酶原激活物受体水平
Schizophr Bull. 2015 May;41(3):764-71. doi: 10.1093/schbul/sbu118. Epub 2014 Aug 25.